Shenzhen Xinqi Medical Technology Co., Ltd.
Unibest Pharma platform portfolio company · IVD test kit development and industrialization
Founded in February 2021, Shenzhen Xinqi Medical Technology Co., Ltd. is an in-vitro diagnostics (IVD) company within the Unibest Pharma platform, licensed for pharmaceutical manufacturing and Class II / III medical device production. Built on immunochromatographic rapid-testing technology, it focuses on inflammatory markers (CRP / PCT / hs-CRP) with at-home saliva-based, blood-free sampling.
Company registry
| Registered name | Shenzhen Xinqi Medical Technology Co., Ltd. |
| USCC | 91440300MA5GLUJY6F |
| Legal representative | Zhongwei Zhao |
| Founded | 2021-02-20 |
| Registered address | Unit 1806, Weisheng Technology Building, 9966 Shennan Ave, Nanshan, Shenzhen |
| Status | Active (in operation) |
Licenses & qualifications
- Drug Manufacturing License (Yue 20230054, contract manufacturing)
- Class II / III medical device manufacturing (business scope)
- Certified SME in science and technology
Business focus
Product line — IVD test kits
View in platform catalog →CRP / Procalcitonin (CRP + PCT) Combo Test Kit
One saliva sample · two markers simultaneously · rapid screening in 3–15 minutes
- 1 + 1 > 2 diagnostic upgrade · CRP is sensitive but less specific; PCT is more specific for bacterial infection but rises later. Combined, they complement each other on speed, accuracy and stability.
- Bacterial / viral triage · C + T1 + T2 all visible suggests bacterial inflammation; C + T1 only suggests viral — giving a basis for antibiotic decisions.
- Non-invasive saliva, home-ready · Most CRP and PCT tests on the market require blood. This kit runs both markers on saliva — no draw, no trauma, friendly to children and the elderly.
C-Reactive Protein (CRP) Test Kit
One saliva sample · patented hollow-gold platform · visual colorimetric reading in 15 minutes
- Non-invasive saliva sampling · Overcomes the complex saliva matrix and correlates salivary CRP with blood inflammatory status — far better compliance for children and the elderly.
- Instrument-free visual reading · No reader or centrifuge required — read against the built-in color card, usable at home, in primary care and in the field.
- Patented hollow-gold platform · Hollow gold nanoparticles carry more antibody on a larger surface area, giving markedly stronger signal amplification than conventional colloidal gold.
High-Sensitivity CRP (hs-CRP) Test Kit
Saliva sample · hollow-gold signal amplification · 3-tier visual cardiovascular risk stratification
- Seeing risk below "normal" · Conventional CRP assays bottom out at 5 mg/L and are effectively blind to low-grade inflammation; hs-CRP pushes detection down to 0.5 mg/L (blood-equivalent).
- Three-tier cardiovascular risk · Maps to the AHA-recommended strata of <1 / 1–3 / ≥3 mg/L (blood-equivalent), turning a binary test into a risk-stratification tool.
- Instrument-free · repeatable at home · C/T lines plus an in-pack 3-level colour card allow testing any time — suited to long-term follow-up, mobile screening vans and community clinics.